Vanberra Signal

ImaCor

Curated by Signal

Hemodynamic management program and technology

Overview

ImaCor is a developer of advanced hemodynamic management program and technology called hTEE (hemodynamic TEE) for the ICU settings. The company develops the hTEE critical care solution, aiming to optimize cardiac performance. The technology is enabled through the Zura ultrasound systems and the miniaturized, disposable ClariTEE probe, designed to remain indwelling for up to 72 hours for episodic assessment of cardiac filling and function. The direct visualization with hTEE enables clinicians to optimize cardiac performance throughout a patient's course of treatment, allowing them to guide and assess the effectiveness of therapies, as well as make critical changes in management at the right time. The products are indicated for patients with high-risk cardiac, VADs and mechanical circulatory support, acute care surgery and trauma.

Key facts

Founded
2004

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Diagnostic devices for sports medicine and trauma centers.

    Life Sciences TechnologyPalo Alto, United States
  • Developer of heart screening devices for providers

    Life Sciences TechnologyLatham, United States
  • Provider of dietary supplements for irritable bowel syndrome

    Life Sciences TechnologyLos Angeles, United States

About ImaCor

What does ImaCor do?

ImaCor is a developer of advanced hemodynamic management program and technology called hTEE (hemodynamic TEE) for the ICU settings.

Where is ImaCor headquartered?

ImaCor is headquartered in Garden City, United States.

When was ImaCor founded?

ImaCor was founded in 2004.

Which sector is ImaCor in?

ImaCor operates in Life Sciences Technology.

Who are ImaCor's competitors?

Companies similar to ImaCor include NeuroDetect, Mesuron, and Nudge.